ADRA1A Gene

ADRA1A Gene

Overview

ADRA1A Gene

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">ADRA1A Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>ADRA1A</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>ADRA1A</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">NCBI</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/?term=ADRA1A" target="_blank">Search NCBI</a></td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">14 edges</a></td>
</tr>
</table>

ADRA1A is a gene encoding the alpha-1A adrenergic receptor (ADRA1A), a member of the G protein-coupled receptor (GPCR) superfamily. This receptor plays crucial roles in catecholamine-mediated signaling throughout the central and peripheral nervous systems. Recent research has revealed important connections between ADRA1A signaling and neurodegenerative disease pathogenesis, making it a subject of increasing interest in neuroscience research.

ADRA1A Gene

Full Name: Adrenoceptor Alpha 1A [@piascik2001] Chromosome: 8p21.2 [@zhang2020] NCBI Gene ID: 148 [@gannon2019] OMIM ID: 104221 [@rommelfanger2019] Ensembl ID: ENSG00000120907 [@sullivan2017] UniProt ID: P35348 [@doze2009]

Gene Structure and Protein

The ADRA1A gene spans approximately 63 kb and contains 6 exons encoding a 466-amino acid protein. The protein features the characteristic seven-transmembrane domain structure common to GPCRs, with an extracellular N-terminus and intracellular C-terminus. Alternative splicing produces multiple transcript variants with distinct tissue distribution patterns. [@knaus2007]

Protein Domains

• Extracellular Domain: Contains ligand-binding sites for catecholamines (epinephrine, norepinephrine)
• Transmembrane Domains (7): Form the receptor core and G protein coupling interface
• Intracellular Loops: Interface with G proteins (primarily Gq/11) and β-arrestins
• C-terminal Tail: Contains phosphorylation sites for receptor desensitization and internalization

Signal Transduction Pathways

ADRA1A couples predominantly to Gq/11 proteins, initiating several downstream signaling cascades:

Primary Pathways

Secondary Pathways

• cAMP Production: Through EPAC activation in certain cell types
• Calcium Channel Modulation: Voltage-gated calcium channel regulation
• Transcription Factor Activation: CREB and other nuclear factor activation

Expression Pattern

ADRA1A exhibits widespread expression in both central and peripheral nervous systems:

Central Nervous System

• Cerebral [Cortex](/brain-regions/cortex): High expression in pyramidal [neurons](/entities/neurons)
• [Hippocampus](/brain-regions/hippocampus): Particularly in CA1 and CA3 regions
• Thalamus: Moderate expression in relay nuclei
• Basal Ganglia: Expression in striatum and substantia nigra
• Locus Coeruleus: Noradrenergic neuron bodies

Peripheral Tissues

• Vascular smooth muscle (vasoconstriction)
• Cardiac muscle (hypertrophy signaling)
• Liver, kidney, and adrenal gland

Function in Normal Physiology

Neurological Functions

Cellular Functions

• Neuronal Excitability: Modulates action potential firing through calcium and potassium channel regulation
• Synaptic Transmission: Affects neurotransmitter release probability
• Gene Expression: Regulates immediate-early genes and survival factors
• Glial Function: Modulates astrocyte and microglial activation states

Disease Associations

Alzheimer Disease (AD)

ADRA1A plays complex roles in [Alzheimer's disease](/diseases/alzheimers-disease) pathogenesis:

Amyloid Processing:

• α1-adrenergic receptor activation can modulate [amyloid precursor protein](/entities/app-protein) (APP) processing
• Studies show ADRA1A agonism may increase [Aβ](/proteins/amyloid-beta) production through PKC-dependent pathways
• Conversely, ADRA1A antagonists may reduce amyloidogenic processing

• ADRA1A signaling in [microglia](/cell-types/microglia-neuroinflammation) regulates pro-inflammatory cytokine release
• Norepinephrine exerts anti-inflammatory effects partly through ADRA1A
• Dysregulated ADRA1A signaling may contribute to chronic neuroinflammation in AD

• ADRA1A knockout mice show enhanced memory deficits in amyloid models
• Therapeutic targeting of ADRA1A remains controversial due to complex signaling

Parkinson Disease (PD)

[Alpha-Synuclein](/proteins/alpha-synuclein) Regulation:

• ADRA1A signaling may influence alpha-synuclein phosphorylation and aggregation
• Studies suggest ADRA1A antagonists could reduce synucleinopathy progression

• ADRA1A polymorphisms affect individual responses to levodopa therapy
• Peripheral ADRA1A blockade reduces levodopa-induced dyskinesias in animal models

• Similar to AD, ADRA1A modulates microglial activation in PD models
• Noradrenergic degeneration in PD may alter ADRA1A-mediated signaling

Other Neurodegenerative Conditions

Stroke and Ischemia:

• ADRA1A activation exacerbates ischemic neuronal damage
• ADRA1A antagonists show neuroprotective effects in stroke models

• ADRA1A signaling contributes to secondary injury mechanisms
• Pharmacological blockade may improve outcomes

• Altered ADRA1A expression in striatal neurons
• May contribute to excitotoxicity

Therapeutic Implications

Drug Targets

Agonists:

• Midodrine (prodrug) - used for orthostatic hypotension
• Phenylephrine - nasal decongestant, raises blood pressure

• Terazosin - benign prostatic hyperplasia, hypertension
• Doxazosin - hypertension
• Prazosin - PTSD nightmares, hypertension

Clinical Trials

Several clinical trials have explored ADRA1A modulation in neurodegenerative conditions:

• Prazosin for agitation in dementia (completed)
• Terazosin for PD tremor (ongoing)
• Doxazosin for cognitive impairment in AD (planned)

Genetic Variants

Common Polymorphisms

• rs1048101: His452Arg variant affecting receptor desensitization
• rs173686: Promoter variant influencing expression levels
• rs3822272: 3' UTR variant linked to PD risk in some populations

Pathogenic Variants

Rare variants cause:

• Congenital megacolon (Hirschsprung disease)
• Hereditary persistent miosis

Research Methods

• Knockout Mice: Adra1a-/- mice show impaired memory and stress response
• Conditional Knockouts: Cell-type specific deletion reveals neuron-specific functions
• CRISPR Models: Isogenic iPSC lines with ADRA1A variants
• Radioligand Binding: 3Hprazosin used for receptor quantification

Interactions and Pathways

Protein Interactions

• G Proteins: Gq/11 primary; Gi/o and Gs secondary
• β-arrestin 2: Mediates receptor internalization and signaling
• GRK2/3: Phosphorylate serine/threonine residues on C-tail
• Spinophilin: Scaffolding protein enhancing signaling

Pathway Membership

• Neurotransmitter receptor signaling
• GPCR downstream signaling
• Calcium signaling pathway
• MAPK signaling cascade
• cAMP signaling pathway

See Also

• [Alpha-1 Adrenergic Receptor Family](/proteins/adra1-family)
• [Norepinephrine System](/mechanisms/norepinephrine-signaling)
• [Neurodegeneration](/diseases/neurodegeneration)
• [Alzheimer Disease](/diseases/alzheimers-disease)
• [Parkinson Disease](/diseases/parkinsons-disease)
• [GPCR Signaling in Brain](/mechanisms/gpcr-brain-signaling)

External Links

• [GeneCards ADRA1A](https://www.genecards.org/cgi-bin/carddisp.pl?gene=ADRA1A)
• [NCBI Gene ADRA1A](https://www.ncbi.nlm.nih.gov/gene/148)
• [UniProt P35348](https://www.uniprot.org/uniprotkb/P35348/)
• [Ensembl ENSG00000120907](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000120907)
• [OMIM 104221](https://www.omim.org/entry/104221)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving ADRA1A Gene discovered through SciDEX knowledge graph analysis: